S

Syncom Formulations (India) Ltd
NSE:SYNCOMF

Watchlist Manager
Syncom Formulations (India) Ltd
NSE:SYNCOMF
Watchlist
Price: 13.55 INR -3.01% Market Closed
Market Cap: 12.7B INR

Operating Margin
Syncom Formulations (India) Ltd

11.1%
Current
10%
Average
5.9%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
11.1%
=
Operating Profit
552.2m
/
Revenue
5B

Operating Margin Across Competitors

No Stocks Found

Syncom Formulations (India) Ltd
Glance View

Market Cap
12.7B INR
Industry
Pharmaceuticals

Syncom Formulation India Ltd. is a pharmaceutical company, which engages in the development, manufacture, and marketing of healthcare products. The company is headquartered in Indore, Madhya Pradesh. The firm manufactures and markets more than 300 pharmaceutical formulations products in various dosage forms, such as tablets, capsules, liquid orals, liquid vials and ampoule injections and dry vial injections, dry syrups, ointments and inhalers. Its segments include Pharmaceuticals Drugs & Formulations, Trading of Commodities and Renting of property. Its product categories include tablets, capsules, ointments, injections, liquid-oral and packaging variants. The company offers various products, including generics, alpha adrenoceptor agonist, analgesic, antipyretic, anti-inflammatory, anti-ulcer agents, antibiotic, antidepressant, antiviral, cephelo sporins, cortico steroid, estrogen, cough suppressant and sedative anticonvulsant, among others. The firm operates in more than 15 countries across the world.

SYNCOMF Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
11.1%
=
Operating Profit
552.2m
/
Revenue
5B
What is the Operating Margin of Syncom Formulations (India) Ltd?

Based on Syncom Formulations (India) Ltd's most recent financial statements, the company has Operating Margin of 11.1%.

Back to Top